Covid-19 roundup: BARDA pumps $60M more into SAB treatment; EMA to decide on boosters next month
SAB Biotherapeutics said Thursday the US federal government is providing it with an additional $60.5 million, and more than $200 million in total, to advance …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.